SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Madrigal Pharmaceuticals, Inc. engages in the development and commercialization of therapeutics for metabolic dysfunction-associated steatohepatitis. The company was founded by Rebecca A. Taub, Frederick Bernard Craves, and Edward Chiang on March 10, 2000 and is headquartered in West Conshohocken, PA.

Madrigal Pharmaceuticals Inc

A former clinical-development executives whistleblower-retaliation lawsuit, alleging problems with Madrigals data and reporting, has raised concerns about Rezdiffras safety and trial integrity; the claims are unproven, and the company disputes them. Traders debate whether the complaint warrants concern or is an employment dispute, while strong Rezdiffra growth and the companys first profitable quarter have not prevented a sharp share-price pullback.

SolarEdge Technologies, Inc. engages in the development of energy technology, which provides inverter solutions. The firm operates through the following segments: Solar and All Other. The Solar segment includes the design, development, manufacturing, and sales of an inverter solution designed to maximize power generation. The All Other segment includes the design, development, manufacturing and sales of UPS products, energy storage products, e-Mobility products, and automated machines. Its products and services include photovoltaic inverters, power optimizers, photovoltaic monitoring, software tools, and electric vehicle chargers. The company was founded by Guy Sella, Lior Handelsman, Yoav Galin, Meir Adest, and Amir Fishelov on August 7, 2006 and is headquartered in Herzliya, Israel.

Solaredge Technologies Inc

SolarEdges latest earnings and softer forward outlook are driving debate: traders note an earnings beat, but weak guidance and continued losses have fueled bearish sentiment and put activity. Others view the selloff as overdone and see potential support from a broader solar-sector rally.

Schwab Strategic Trust - Schwab US Dividend Equity ETF

Schwab US Dividend Equity ETF

SCHD is drawing attention as investors discuss its role as a defensive, dividend-focused alternative to volatile technology and growth stocks, amid shifting market leadership. Traders are divided between accumulating it for income and stability and citing rising Treasury yields or renewed tech strength as reasons for its recent weakness.

Sunrun, Inc. engages in the design, development, installation, sale, ownership, and maintenance of residential solar energy systems. It sells solar service offerings and installs solar energy systems for homeowners. Customers can access its products through three channels: direct-to-consumer, solar partnerships, and strategic partnerships. The company was founded by Edward Harris Fenster, Robert Nat Kreamer, and Lynn Michelle Jurich in January 2007 and is headquartered in San Francisco, CA.

Sunrun Inc

Sunruns Q3 results beating expectations drove the latest burst of attention, with traders focusing on the earnings-driven rebound and high short interest as potential fuel for a squeeze. Bullish reactions contend the results show improving performance, while skeptics point to cash-generation and outlook concerns, debt, and the stocks volatility.

Select Sector SPDR Trust (The) - State Street Consumer Staples Select Sector SPDR ETF

Consumer Staples Select Sector SPDR Fund

A rotation into defensive consumer staples amid weakness in technology and AI-related shares has driven attention to XLP, with traders noting its strong run and recent highs. The community is divided over whether the move can continue or is overextended and due for a pullback; put-heavy options activity is being discussed as possible hedging, not confirmed bearish positioning.

Amplify Commodity Trust - Breakwave Tanker Shipping ETF

Breakwave Tanker Shipping ETF

A sharp pullback in tanker freight futures is driving bearish discussion, with traders pointing to falling shipping rates, put activity, and concern that BWETs war-driven rally may be reversing. Others argue that ongoing Middle East shipping disruption could keep freight rates elevated, leaving the ETFs outlook highly volatile.

Snowflake, Inc. engages in the provision of cloud data warehousing software. The firm offers Data Cloud, an ecosystem where Snowflake customers, partners, data providers, and data consumers can break down data silos and derive value from data. Its platform supports a range of use cases including data warehousing, data lakes, data engineering, data science, data application development, and data sharing. The cloud-native architecture consists of layers across storage, compute, and cloud services. The storage layer ingests structured and semi-structured data to create a unified data record. The compute layer provides dedicated resources to enable users to access common data sets for many use cases without latency. The cloud services layer optimizes each use case's performance requirements with no administration. The company was founded by Marcin Zukowski, Thierry Cruanes, and Benoit Dageville on July 23, 2012 and is headquartered in Menlo Park, CA.

Snowflake Inc

Traders are focused on whether Snowflakes consumption-based revenue can hold up if AI pilots are audited or customer budgets tighten, with concerns that reduced queries and canceled workloads could weaken growth. The stocks bounce after a recent selloff has drawn some buyers, while others remain wary of the usage models exposure to spending cuts.

Starbucks Corp. engages in the production, marketing, and retailing of specialty coffee. It operates through the following segments: North America, International, and Channel Development. The North America segment focuses on the United States and Canada. The International segment is involved in China, Japan, Asia Pacific, Europe, Middle East, Africa, Latin America, and Caribbean. The Channel Development segment includes roasted whole bean and ground coffees, Seattle’s Best Coffee, and Teavana-branded single-serve products. The company was founded by Jerry Baldwin and Howard D. Schultz on November 4, 1985, and is headquartered in Seattle, WA.

Starbucks Corp.

Starbucks Corp

Starbucks latest quarterly results are driving attention: stronger-than-expected comparable sales and earnings contrast with a revenue miss tied partly to the China restructuring and cautious sales outlook. Traders are split between seeing improving U.S. traffic and turnaround progress as encouraging, and viewing the revenue outlook and valuation as reasons for caution.

Target Corp. engages in the operation and ownership of general merchandise stores. It offers food and general merchandise, clothing and household goods, electronics, and toys. Its brands include A New Day, All in Motion, Art Class, Auden, AVA & VIV, Boots and Barkley, Brightroom, Bullseye's Playground, Casaluna, Cat & Jack, Cloud Island, Colsie, dealworthy, Embark, Everspring, Favorite Day, Figmint, Future Collective, Gigglescape, Good & Gather, Goodfellow & Co, Hearth & Hand with Magnolia, Heyday, Hyde & EEK! Boutique, JoyLab, Kindfull, Kona Sol, Made By Design, Market Pantry, Mondo Llama, More Than Magic, Opalhouse, Open Story, Original Use, Pillowfort, Project 62, Room Essentials, Shade & Shore, Smartly, Smith & Hawken, Sonia Kashuk, Spritz, Sun Squad, Threshold, Universal Thread, up&up, Wild Fable, Wondershop, Xhilaration, California Roots, Casa Cantina, The Collection, Headliner, Jingle & Mingle, Rosé Bae, Photograph, SunPop, and Wine Cube. The company was founded by George Draper Dayton in 1902 and is headquartered in Minneapolis, MN.

Target Corp

Targets relative strength during a tech-led market pullback has traders framing it as part of a rotation into defensive retail and consumer staples. Bulls point to the companys turnaround and bullish chart setup, while skeptics question consumer spending and the durability of the rally.

MGM Resorts International is a holding company, which engages in the ownership and operations of casino resorts. The firm's casino resorts offer gaming, hotel, convention, dining, entertainment, retail, and other resort amenities. It operates through the following business segments: Las Vegas Strip Resorts, Regional Operations, MGM China, and MGM Digital. The Las Vegas Strip Resorts segment operates the following casino resorts: Bellagio, MGM Grand Las Vegas, Mandalay Bay, The Mirage, Luxor, New York-New, Excalibur, Park MGM, and Circus Las Vegas. The Regional Operations segment consists of the following casino resorts: MGM Grand Detroit in Detroit, Michigan, Beau Rivage in Biloxi, Mississippi, Gold Strike Tunica in Tunica, Mississippi, Borgata in Atlantic City, New Jersey, MGM National Harbor in Prince George’s County, Maryland, and MGM Springfield in Springfield, Massachusetts. The MGM China segment includes MGM Macau and MGM Cotai. The MGM Digital segment focuses on the online gaming portfolio, which consists primarily of Leo Vegas, which is headquartered in Sweden and Malta. The company was founded by Kerkor Kerkorian on January 29, 1986 and is headquartered in Las Vegas, NV.

MGM Resorts International

Director Keith Meisters reported large open-market purchase is drawing attention, with traders treating it as a bullish signal and fueling speculation about a renewed buyout or other deal. Others caution that the purchase does not confirm negotiations, while bearish sentiment persists over MGMs weak performance and the casino sectors downturn.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

TEVA Stock Hits Fresh 52-Week High As FDA Approves Monthly Schizophrenia Shot 

Equity

The U.S. Food and Drug Administration approved Weltruza as an extended-release injectable suspension for adults with schizophrenia.

NBIS Stock Surges After Nebius Q2 Revenue Soars 454% — CEO Says Demand For AI Capacity ‘Continues To Grow Exponentially’

Nebius CEO Arkady Volozh stated that this quarter was when the market validated the company’s strategy.


SE Stock On Track To Hit A 6-Month High Despite Mixed Q2 — CEO Bets Shopee Can Hit $1B Adjusted EBITDA In 2026

Sea reported earnings per share of $0.7 on revenue of $7.8 billion, while Wall Street expected an EPS of $0.86 on revenue of $7.1 billion, according to Fiscal.ai data.


Noteworthy ETF Outflows: EFA, SPOT, NBIS, TEVA

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares MSCI EAFE ETF (Symbol: EFA) where we have detected an approximate $123.1 million dollar outflow -- that's a 0.2% decrease week over week (fr...

Noteworthy ETF Outflows: EFA, NBIS, SUNB, AER

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares MSCI EAFE ETF (Symbol: EFA) where we have detected an approximate $309.4 million dollar outflow -- that's a 0.4% decrease week over week (fr...

NBIS Stock Hits Fresh 52-Week Highs — Wall Street Says Nebius Is Innovating Faster Than Its Peers

Nebius reported a massive 684% year-on-year surge in its first-quarter revenue on Wednesday and increased its guidance for capacity addition through 2026.

Nebius Reports Whopping 684% Jump In Q1 Revenue, Secures Power For New 1.2 GW Facility — CEO Touts ‘Unprecedented Demand’

Nebius reported adjusted earnings per share of $2.11 in Q1, compared to a loss of $0.48 per share during the same period a year ago.

Sea Delivers A Mixed Q1, CEO Highlights Improving Unit Economics — 'Significant Runway For Growth Still Ahead Of Us'

The Singapore-based tech conglomerate reported earnings per share of $0.67 on revenue of $7.1 billion, while Wall Street analysts expected an EPS of $0.77 on revenue of $6.4 billion.

NBIS Stock Rides AI Infrastructure Wave To Soar 600% In A Year — Analysts Say Nebius Presents A 'Huge Opportunity'

The surge in NBIS stock comes amid a slew of developments, including the construction of a new 310-megawatt AI factory in Finland and an expanding partnership with Nvidia.

What Is Pulling NBIS Stock Down Today?

The company said it will offer the convertible notes in two series totaling $3.75 billion, with $2 billion in the first and $1.75 billion in the second.

iShares Trust - iShares MSCI EAFE ETF

Bullish Sentiment

<ul class="summary-bullets"><li>Approval rests on the late-stage SOLARIS study, where investigators reported better overall symptoms, a clear drop in illness severity, and gains in personal and social functioning.</li><li>Weltruza uses SteadyTeq, a slow-release technology from French partner Medincell.</li><li>European regulators accepted a marketing application for Weltruza in May 2026; that review is still open.</li></ul><p>NYSE-listed shares of Teva Pharmaceutical Industries (TEVA) rallied on Friday, touching fresh 52-week highs, after the company won U.S. FDA approval for a once-monthly schizophrenia injection, extending a strong year for the stock.</p><p>TEVA stock rose as high as $42.02 and was up 6% at the time of writing.</p><h2 class="st-heading-2">FDA Clears First Once-Monthly Olanzapine Shot</h2><p>The U.S. Food and Drug Administration approved Weltruza (olanzapine) for extended-release injectable suspension for adults with schizophrenia. Teva said it is the first and only once-monthly shot of olanzapine given under the skin.</p><p>The drug will come in three strengths—318 mg, 425 mg, and 531 mg—matching the usual daily oral doses of 10 mg, 15 mg, and 20 mg. Patients will not need starter doses, extra oral pills, or observation after each injection. Teva expects U.S. availability in the coming weeks.</p><h2 class="st-heading-2">TEVA’s Late-Stage Trial Showed Symptom Gains</h2><p>Approval rests on the late-stage SOLARIS study. Investigators reported better overall symptoms, a clear drop in illness severity, and gains in personal and social functioning. Side effects matched those of oral olanzapine. The most common were weight gain, sleepiness, headache, constipation, and reactions at the injection site. Dropouts linked to common side effects were similar to placebo.</p><p>Olanzapine has been a widely used daily pill for schizophrenia for more than 30 years. Missed doses can raise the risk of relapse. About 2.1 million people in the United States have a schizophrenia diagnosis. Chris Fox, who leads Teva’s U.S. commercial business, said the shot was built around that adherence problem. Chief Medical Officer Eric Hughes said the under-the-skin design removes the need for monitoring after every dose.</p><h2 class="st-heading-2">Medincell- TEVA Partnership, U.S. Launch Timing, And Europe Review</h2><p>Weltruza uses SteadyTeq, a slow-release technology from French partner Medincell. It is the second U.S. product from that alliance, after Uzedy, a long-acting risperidone shot approved in 2023.</p><p>European regulators accepted a marketing application for Weltruza in May 2026; that review is still open.</p><h2 class="st-heading-2">How Did TEVA Retail Traders React?</h2><p>On Stocktwits, retail sentiment around TEVA stayed within neutral territory over the past 24 hours, while message volume rose from normal to high levels.</p><p>A Stocktwits user said that the stock pays to hold and voiced optimism for a further rally to $45.</p><p><stembedurl>https://stocktwits.com/Orbit100/message/666150887</stembedurl></p><p><a href="https://stocktwits.com/symbol/TEVA">TEVA stock</a> has gained 34% year-to-date.&nbsp;</p><p>Read More: <a href="https://stocktwits.com/news-articles/markets/equity/fsly-rockets-nearly-16-oppenheimer-upgrades-stock-as-analyst-sees-agentic-ai-driving-sustained-growth/cZD6HcIRBnB">FSLY Rockets Nearly 16%: Oppenheimer Upgrades Stock As Analyst Sees Agentic AI Driving Sustained Growth</a></p><p><i>For updates and corrections, email newsroom[at]stocktwits[dot]com</i></p>

In this photo illustration, Teva Pharmaceutical Industries’ logo is displayed on a smartphone with an economic stock exchange index graph in the background. (Photo Illustration by Budrul Chukrut/SOPA Images/LightRocket via Getty Images)

Approval rests on the late-stage SOLARIS study, where investigators reported better overall symptoms, a clear drop in illness severity, and gains in personal and social functioning.Weltruza uses SteadyTeq, a slow-release technology from French partner Med

TEVA Stock Hits Fresh 52-Week High As FDA Approves Monthly Schizophrenia Shot

iShares MSCI EAFE ETF

iShares Core MSCI EAFE ETF

Teva- Pharmaceutical Industries Ltd. - ADR

Up more than 1% 

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Feed

News

Sentiment

Fundamentals

Info

EFA iShares MSCI EAFE ETF

Fundamentals

Latest EFA News